Coronary heart disease (CHD) is one of the leading causes of disability and death worldwide, which includes angina pectoris, myocardial infarction, as well as arterial sclerosis of the coronary arteries [1] . It is widely accepted that CHD is a multifactorial disease. Several factors (hereditary, social-environmental factors, and their interactions) contribute to the onset of CHD.
The interleukin-6 (IL-6) gene locates on 7p21. Previous epidemiological studies revealed that plasma levels of IL-6 in people with cardiovascular disease (CVD) are quite different from those without CVD [2, 3] . Till now, many studies have investigated the association between IL-6 gene -572G>C polymorphism and CHD risk. However, the results are inconsistent. In order to avoid the limitations of single case-control study and to provide renewed evidence, we performed this meta-analysis and tried to give a more comprehensive estimation of association between IL-6 gene -572G>C polymorphism and CHD susceptibility.
We searched in PubMed, EMBASE, EBSCO, and Chinese National Knowledge Infrastructure (CNKI) to retrieve relevant studies until May 1, 2016. Studies were considered eligible if they met the following criteria: (1) it was a case-control study in design; (2) it evaluated the IL-6 gene -572G>C polymorphism and CHD susceptibility; (3) the diagnosis of CHD was definite; (4) sample sizes and individual genotype frequencies were available. Two reviewers independently searched and selected literature, and extracted relevant data according to a data extraction form. Disagreements were solved by discussion until consensus was made.
For each included study, the quality assessment was conducted according to STREGA (STrengthening the REporting of Genetic Association studies). Data analysis was conducted using STATA 11.0 software (Stata Statistical software, USA, www. stata.com). Odds ratio (OR) and its corresponding 95% confidence intervals (95% CI) were used to evaluate the strength of association. Heterogeneity among included studies was tested using c 2 -based Q test and I 2 test. The Mantel-Haenszel method was used for fix-effect model if no heterogeneity was found. Otherwise, the DerSimonian-Laird random-effect model was used. Five comparisons of genetic models were conduced, including the dominant model (GG+GC vs. CC), the recessive model (GG vs. GC+CC), the allele contrast genetic model (G vs. C), the heterozygote comparison (GC vs. CC), and the homozygote comparison (GG vs. CC). Sensitivity analyses were conducted by omitting individual studies sequentially. Publication bias was quantitatively assessed by Begg's rank correlation test. Subgroup analyses stratified by ethnicity, source of control and deviation from Hardy-Weinberg equilibrium (HWE) were conducted. Meta-regression test was used for the assessment of heterogeneity, characteristics tested included ethnicity, source of control, deviation from HWE, and sample size. P < 0.05 showed statistical significance.
Finally, 19 case-control studies including 4,545 cases and 7,720 controls were included in this meta-analysis. Table 1 presents the main characteristics, genotype frequencies of included studies, deviation from HWE in control groups, and quality of each study. The combined results based on all Table 1 . The main characteristics of studies included in this meta-analysis and the distribution of IL-6 gene -572G>C genotypic frequency and allelic frequency among the cases and controls. CI -confidence interval; HB -hospital-based study; HWE -Hardy-Weinberg equilibrium; OR -odds ratio; PB -population-based study Figure 1 . The association between IL-6 gene -572G>C polymorphism and coronary heart disease susceptibility in the allele contrast genetic model stratified by ethnicity; CI -confidence interval; OR -odds ratio.
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shows the association between IL-6 gene -572G>C polymorphism and CHD susceptibility in the allele contrast genetic model stratified by ethnicity. Through Begg's rank correlation test, we identified heterogeneity in the dominant model, the allele contrast genetic model, and the homozygote comparison, but not for the other two genetic models. In the sensitivity analyses, the result did not change under any genetic model, which suggested that the results of main analysis were statistically robust. In meta-regression, the univariate regression test showed that ethnicity (I 2 -residual = 40.1%, adj-R 2 = 41.8%, p = 0.04) were the significant source of heterogeneity among studies.
Cytokine genes have been supposed to be of crucial role in diseases susceptibility and host genetic polymorphisms. IL-6 has a broad range of cellular and humoral properties in relation to the etiology and inflammatory response of CHD [4, 5] . Previous studies have demonstrated that plasma levels of IL-6 may be associated with CHD risk and that the -572G allele was associated with lower serum level of IL-6 concentrations compared with the -572C allele [6, 7] . Therefore, it is quite reasonable to deduce that IL-6 gene -572G>C polymorphism is associated with CHD susceptibility.
Comparing with two previous meta-analyses focusing on association between IL-6 gene -572G>C polymorphism [8, 9] , our study has some important improvements. Firstly, some new studies were published and they were included in our meta-analysis. Moreover, in the present study, we conducted subgroup analyses and metaregression test to identify the potential source of heterogeneity. Through subgroup analyses, we found that G allele of -572G>C polymorphism was significantly associated with increased CHD susceptibility in Asians, but the effect size was weak. Meta-regression test showed that ethnicity (I 2 -residual = 40.1%, adj-R 2 = 41.8%, p = 0.04) was a significant source of heterogeneity among the studies. Therefore, the different ethnicity contributed to the overall heterogeneity. We also have to note the limitations of this study. Firstly, we only included published studies meeting our inclusion criteria from four databases, similar studies in other databases and unpublished researches may have been missed. Moreover, the possible pathogenesis of CHD is comprehensive, but due to insufficiency of included studies, we did not detect the interactions between genetic factors and other environmental or lifestyle factors.
In conclusion, from the combined results of currently included studies, our meta-analysis suggests that the G allele of IL-6 gene -572G>C polymorphism is significantly associated with increased CHD susceptibility in Asians, but the effect size is weak. More studies with multiple ethnicities and different genders are needed to generalize the results.
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